{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:14:14Z","timestamp":1790162054716,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jid.2017.02.980","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T09:47:20Z","timestamp":1489139240000},"page":"1523-1532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["BCL11B-Mediated Epigenetic Repression Is a Crucial Target for Histone Deacetylase Inhibitors in Cutaneous T-Cell Lymphoma"],"prefix":"10.1016","volume":"137","author":[{"given":"Wenjing","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengguo","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2017.02.980_bib1","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1038\/jid.2012.125","article-title":"Apoptosis induction by SAHA in cutaneous T-cell lymphoma cells is related to downregulation of c-FLIP and enhanced TRAIL signaling","volume":"132","author":"Al-Yacoub","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2017.02.980_bib2","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.4049\/jimmunol.1400930","article-title":"The multifaceted roles of Bcl11b in thymic and peripheral T cells: impact on immune diseases","volume":"193","author":"Avram","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2017.02.980_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.trsl.2014.05.003","article-title":"The nucleosome remodeling and deacetylase complex in development and disease","volume":"165","author":"Basta","year":"2015","journal-title":"Transl Res"},{"key":"10.1016\/j.jid.2017.02.980_bib4","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jid.2017.02.980_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/jid.2011.316","article-title":"Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand","volume":"132","author":"Braun","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2017.02.980_bib6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/bjc.2016.36","article-title":"Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia","volume":"114","author":"Ceccacci","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jid.2017.02.980_bib7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous T cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nature Genet"},{"issue":"45","key":"10.1016\/j.jid.2017.02.980_bib8","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1038\/sj.onc.1208904","article-title":"BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter","volume":"24","author":"Cismasiu","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2017.02.980_bib9","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archderm.143.7.854","article-title":"Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002","volume":"143","author":"Criscione","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2017.02.980_bib10","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/ng.3442","article-title":"The mutational landscape of cutaneous T cell lymphoma and Sezary syndrome","volume":"47","author":"da Silva Almeida","year":"2015","journal-title":"Nature Genet"},{"key":"10.1016\/j.jid.2017.02.980_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jid.2017.02.980_bib12","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/nm.2246","article-title":"The TLX1 oncogene drives aneuploidy in T cell transformation","volume":"16","author":"De Keersmaecker","year":"2010","journal-title":"Nat Med"},{"issue":"5987","key":"10.1016\/j.jid.2017.02.980_bib13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1191664","article-title":"Immunology. A guardian of T cell fate","volume":"329","author":"Di Santo","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jid.2017.02.980_bib14","article-title":"Histone deacetylase inhibitors interrupt HSP90 RASGRP1 and HSP90 CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cells","author":"Ding","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.jid.2017.02.980_bib15","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1128\/MCB.00062-16","article-title":"Protein kinase C-mediated phosphorylation of BCL11B at serine 2 negatively regulates its interaction with NuRD complexes during CD4+ T-cell activation","volume":"36","author":"Dubuissez","year":"2016","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jid.2017.02.980_bib16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3816\/CLM.2009.n.082","article-title":"Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphoma","volume":"9","author":"Duvic","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.jid.2017.02.980_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood-2006-06-025999","article-title":"Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)","volume":"109","author":"Duvic","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jid.2017.02.980_bib18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.canlet.2008.06.005","article-title":"Histone deacetylase inhibitors and genomic instability","volume":"274","author":"Eot-Houllier","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jid.2017.02.980_bib19","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/leu.2015.9","article-title":"BIN1 tumor suppressor regulates Fas\/Fas ligand-mediated apoptosis through c-FLIP in cutaneous T-cell lymphoma","volume":"29","author":"Esmailzadeh","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.jid.2017.02.980_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2141.2009.07887.x","article-title":"Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors","volume":"147","author":"Gloghini","year":"2009","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.jid.2017.02.980_bib21","doi-asserted-by":"crossref","first-page":"e12532","DOI":"10.1371\/journal.pone.0012532","article-title":"Increased expression of bcl11b leads to chemoresistance accompanied by G1 accumulation","volume":"5","author":"Grabarczyk","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2017.02.980_bib22","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1038\/sj.onc.1210152","article-title":"Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells","volume":"26","author":"Grabarczyk","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2017.02.980_bib23","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/1346-8138.12160","article-title":"Aberrant expression of BCL11B in mycosis fungoides and its potential role in interferon-induced apoptosis","volume":"40","author":"Gu","year":"2013","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jid.2017.02.980_bib24","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1182\/blood-2010-11-318873","article-title":"The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia","volume":"118","author":"Gutierrez","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jid.2017.02.980_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2017.02.980_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2008","journal-title":"Nat Protocols"},{"key":"10.1016\/j.jid.2017.02.980_bib27","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.18632\/oncotarget.2031","article-title":"Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis","volume":"5","author":"Huang","year":"2014","journal-title":"Oncotarget"},{"issue":"5987","key":"10.1016\/j.jid.2017.02.980_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.1188995","article-title":"An essential developmental checkpoint for production of the T cell lineage","volume":"329","author":"Ikawa","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jid.2017.02.980_bib29","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ng.3358","article-title":"Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma","volume":"47","author":"Jiang","year":"2015","journal-title":"Nature Genet"},{"key":"10.1016\/j.jid.2017.02.980_bib30","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.bbrc.2007.02.003","article-title":"Haploinsufficiency of Bcl11b for suppression of lymphomagenesis and thymocyte development","volume":"355","author":"Kamimura","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jid.2017.02.980_bib31","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1111\/febs.13047","article-title":"Novel types and sites of histone modifications emerge as players in the transcriptional regulation contest","volume":"282","author":"Kebede","year":"2015","journal-title":"FEBS J"},{"key":"10.1016\/j.jid.2017.02.980_bib32","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1038\/onc.2015.435","article-title":"MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas","volume":"35","author":"Kitadate","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2017.02.980_bib33","doi-asserted-by":"crossref","first-page":"15235","DOI":"10.18632\/oncotarget.3837","article-title":"Malignant T cells express lymphotoxin alpha and drive endothelial activation in cutaneous T cell lymphoma","volume":"6","author":"Lauenborg","year":"2015","journal-title":"Oncotarget"},{"issue":"5987","key":"10.1016\/j.jid.2017.02.980_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.1188989","article-title":"An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jid.2017.02.980_bib35","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood-2012-08-447839","article-title":"A\u00a0far downstream enhancer for murine Bcl11b controls its T-cell specific expression","volume":"122","author":"Li","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jid.2017.02.980_bib36","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1365-2133.2002.04966.x","article-title":"Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sezary\u00a0syndrome and mycosis fungoides","volume":"147","author":"Mao","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2017.02.980_bib37","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jid.2017.02.980_bib38","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2006.10.2434","article-title":"Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma","volume":"25","author":"Olsen","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2017.02.980_bib39","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1158\/1078-0432.CCR-08-2785","article-title":"Clinical studies of histone deacetylase inhibitors","volume":"15","author":"Prince","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2017.02.980_bib40","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1074\/mcp.M113.037127","article-title":"Suberoylanilide hydroxamic acid (SAHA)-induced dynamics of a human histone deacetylase protein interaction network","volume":"13","author":"Sardiu","year":"2014","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"10.1016\/j.jid.2017.02.980_bib41","doi-asserted-by":"crossref","first-page":"e53766","DOI":"10.1371\/journal.pone.0053766","article-title":"Vorinostat induces apoptosis and differentiation in myeloid malignancies: genetic and molecular mechanisms","volume":"8","author":"Silva","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2017.02.980_bib42","doi-asserted-by":"crossref","first-page":"1327.e1","DOI":"10.1016\/j.jaad.2012.05.035","article-title":"The Fas apoptotic pathway in cutaneous T-cell lymphomas: frequent expression of phenotypes associated with resistance to apoptosis","volume":"67","author":"Stutz","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2017.02.980_bib43","doi-asserted-by":"crossref","first-page":"32272","DOI":"10.1074\/jbc.M602776200","article-title":"CTIP2 associates with the NuRD complex on the promoter of p57KIP2, a newly identified CTIP2 target gene","volume":"281","author":"Topark-Ngarm","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2017.02.980_bib44","doi-asserted-by":"crossref","first-page":"E3306","DOI":"10.1073\/pnas.1412327111","article-title":"Dissecting the dynamic changes of 5-hydroxymethylcytosine in T-cell development and differentiation","volume":"111","author":"Tsagaratou","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2017.02.980_bib45","first-page":"816","article-title":"Allogeneic haematopoietic stem cell transplantation for patients with cutaneous T-cell lymphoma","volume":"96","author":"Vakeva","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2017.02.980_bib46","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/ng.3444","article-title":"Genomic profiling of Sezary syndrome identifies alterations of key T cell signaling and differentiation genes","volume":"47","author":"Wang","year":"2015","journal-title":"Nature Genet"},{"key":"10.1016\/j.jid.2017.02.980_bib47","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1182\/blood-2010-07-294819","article-title":"Deficiency of SATB1 expression in Sezary cells causes apoptosis resistance by regulating FasL\/CD95L transcription","volume":"117","author":"Wang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jid.2017.02.980_bib48","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2009.06.049","article-title":"Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes","volume":"138","author":"Wang","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jid.2017.02.980_bib49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ajh.24233","article-title":"Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management","volume":"91","author":"Wilcox","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jid.2017.02.980_bib50","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jid.2016.01.028","article-title":"Independent loss of methylthioadenosine phosphorylase (MTAP) in primary cutaneous T-cell lymphoma","volume":"136","author":"Woollard","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2017.02.980_bib51","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nn.4322","article-title":"Zeb2 recruits HDAC-NuRD to inhibit Notch and controls Schwann cell differentiation and remyelination","volume":"19","author":"Wu","year":"2016","journal-title":"Nature Neurosci"},{"key":"10.1016\/j.jid.2017.02.980_bib52","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S1097-2765(00)80299-3","article-title":"NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities","volume":"2","author":"Xue","year":"1998","journal-title":"Mol Cell"},{"key":"10.1016\/j.jid.2017.02.980_bib53","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.0022-202X.2005.23925.x","article-title":"Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action","volume":"125","author":"Zhang","year":"2005","journal-title":"J\u00a0Invest Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17312162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17312162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T17:27:12Z","timestamp":1535995632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X17312162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0022202X17312162"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2017.02.980","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCL11B-Mediated Epigenetic Repression Is a Crucial Target for Histone Deacetylase Inhibitors in Cutaneous T-Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2017.02.980","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}